Mirikizumab Tops Placebo for Moderately-to-Severely Active Ulcerative Colitis
Mirikizumab more effective for inducing and maintaining clinical remission in patients with ulcerative colitis
Report Estimates Costs of Birth Defect-Associated Hospitalizations
Total estimated cost of birth defect-associated hospitalizations was $22.2 billion in the United States in 2019
1999 to 2020 Saw Decrease in Cancer-Specific Mortality in Hispanic Adults
Cancer-specific mortality rates decreased more for Hispanic men than women
Clinical, Metabolic Factors Influence T2D Remission After Gastric Bypass
More than half of patients in remission six years after surgery, regardless of weight loss
Metabolic Surgery Cuts Cardiovascular Events for Obesity, Sleep Apnea
Risk reduced by more than one-third versus matched individuals without surgery
Hormone Therapy May Up Odds of GERD in Postmenopausal Women
Significant direct association seen between estrogen use, progestogen use, combined hormone therapy with gastroesophageal reflux disease
Incidence of Foodborne Pathogens Back to Prepandemic Levels
Annual incidences of illnesses caused by Campylobacter, Salmonella, Shigella, and Listeria during 2022 similar to those during 2016 to 2018
Cardiorespiratory Fitness Tied to Reduced Cancer Incidence, Mortality in Men
Moderate, high CRF linked to lower colon cancer incidence; low, moderate, high CRF linked to lower prostate cancer mortality
Risk Factors Identified for Early-Onset Sporadic Colorectal Cancer
Independent risk factors include age, body mass index, comorbidity, first- or second-degree relative with CRC, alcohol use
Learning Curve Length Estimated for Minimally Invasive Distal Pancreatectomy
Learning curve for primary textbook outcome was 85 procedures, with primary textbook outcome rate plateauing at 70 percent
